MACROGENICS, INC. ( NASDAQ: MGNX ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline
I'm PortAI, I can summarize articles.
Bernstein Liebhard LLP is reminding investors of MacroGenics, Inc. (NASDAQ: MGNX) about a deadline to file a lead plaintiff motion in a securities class action lawsuit. This lawsuit pertains to investors who bought shares between March 7, 2024, and May 9, 2024, and alleges violations of the Securities Exchange Act due to misrepresentations regarding safety data from a prostate cancer drug study. The deadline to file is September 24, 2024.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments